Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$9,471,303
+$448,779 QoQ
Shares Held
37,293
+1.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.26%
of 13F equity value
Holder Rank
#1,143
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ipswich Investment Management Co., Inc. holds $39,266,096 across 11 Drug Manufacturers - General names. JNJ ranks #1 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
37,293 | $9,471,303 | |
| 2 | LLY |
ELI LILLY & Co
|
6,727 | $8,068,566 | |
| 3 | MRK |
Merck & Co., Inc.
|
46,912 | $6,028,192 | |
| 4 | AMGN |
Amgen Inc
|
15,234 | $5,516,536 | |
| 5 | ABBV |
AbbVie Inc.
|
11,896 | $2,993,509 | |
| 6 | NVS |
Novartis AG
|
16,585 | $2,599,201 | |
| 7 | NVO |
Novo Nordisk A S
|
50,411 | $2,416,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
17,229 | $992,734 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,471,303 | 37,293 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $9,022,524 | 36,911 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $7,758,348 | 37,489 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $7,028,159 | 37,904 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $5,923,034 | 38,776 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $6,621,327 | 39,926 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $6,117,426 | 42,300 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $6,942,326 | 42,838 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $6,326,974 | 43,288 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $6,933,151 | 43,828 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $7,441,701 | 47,478 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $7,859,768 | 50,464 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,454,596 | 51,079 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $8,009,160 | 51,672 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $9,092,705 | 51,473 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $8,437,707 | 51,651 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $9,464,833 | 53,320 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $9,190,084 | 51,854 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $9,028,903 | 52,779 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $8,581,787 | 53,138 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $8,760,543 | 53,178 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $8,564,771 | 52,113 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $8,028,268 | 51,012 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $7,916,694 | 53,175 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $7,425,264 | 52,800 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $7,211,756 | 54,997 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||